ZTS

ZOETIS
D

ZTS

176.390
USD
1.09
(0.62%)
Market Open
Volume
48,301
EPS
6
Div Yield
0.99
P/E
33
Market Cap
79,580,996,290
Signals
Related Instruments
    NEOUSD
    NEOUSD
    -0.110
    (-0.65%)
    18.269 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    277.52 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    IDXX
    IDXX
    -2.54
    (-0.60%)
    421.30 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    100.620 USD
    N
    NEO
    -0.770
    (-4.87%)
    15.030 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    104.780 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.855 USD
    SNY
    SNY
    0.160
    (0.33%)
    48.010 USD
    More
News

Title: ZOETIS

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.